EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer cachexia: biomarkers and the influence of age

Julia Geppert, Maria Rohm iD

Molecular Oncology · 27.02.2024

DOI: 10.1002/1878-0261.13590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 27.02.2024. Verfasst von Julia Geppert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Aging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz-Gemeinschaft, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia (Ccx) is a complex metabolic condition characterized by pronounced muscle and fat wasting, systemic inflammation, weakness and fatigue. Up to 30% of cancer patients succumb directly to Ccx, yet therapies that effectively address this perturbed metabolic state are rare. In recent decades, several characteristics of Ccx have been established in mice and humans, of which we here highlight adipose tissue dysfunction, muscle wasting and systemic inflammation, as they are directly linked to biomarker discovery. To counteract cachexia pathogenesis as early as possible and mitigate its detrimental impact on anti‐cancer treatments, identification and validation of clinically endorsed biomarkers assume paramount importance. Ageing was recently shown to affect both the validity of Ccx biomarkers and Ccx development, but the underlying mechanisms are still unknown. Thus, unravelling the intricate interplay between ageing and Ccx can help to counteract Ccx pathogenesis and tailor diagnostic and treatment strategies to individual needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsAgingHumansAnimalsBiomarkersBiomarkers, TumorInflammation

Stichwörter der Autor:innen

ageingbiomarkercachexiacancerinflammationmetabolism

Substanzen

BiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
  • Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Germany.
  • German Center for Diabetes Research (DZD), Neuherberg, Germany.

ORCID-Profile: Maria Rohm

Förderung

  • Helmholtz-Gemeinschaft
  • European Commission

Zitieren

APA

Geppert, J., & Rohm, M. (2024). Cancer cachexia: biomarkers and the influence of age. Molecular Oncology. https://doi.org/10.1002/1878-0261.13590

Vancouver

Geppert J, Rohm M. Cancer cachexia: biomarkers and the influence of age. Molecular Oncology. 2024. doi:10.1002/1878-0261.13590

BibTeX
@article{Geppert2024,
  author = {Geppert, Julia and Rohm, Maria},
  title = {Cancer cachexia: biomarkers and the influence of age},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13590}
}
Kostenlos starten →